Navidea seeking EU approval for Lymphoseek

Navidea Biopharmaceuticals Inc. (NYSE-M:NAVB) submitted an MAA to EMA for Lymphoseek tilmanocept for use in intraoperative lymphatic imaging. Navidea said the MAA covers the use of Lymphoseek for gene...